AbbVie Calls Retailers' Bystolic Generic Delay Claims Flawed
By Christopher Cole · September 21, 2021, 6:51 PM EDT
AbbVie has urged a New York federal judge to toss complaints from retailers CVS and Walgreens accusing the drugmaker of plotting to keep generic forms of the blockbuster drug Bystolic off...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login